Skip to main content

Clinical

Should hazardous scientific information be made public?
GARRISON, N.Y. | What should be done with scientific findings that can be used for good or evil? A report by the Hastings Center examines this question in relation to the controversial decision to allow full publication last year of two papers on genetically engineered strains of the H5N1 avian influenza virus.
Funding awarded for 17 genomic research projects
OTTAWA | New Canadian bioinformatics and computational biology research projects will help manage, analyze and interpret vast amounts of genomics data to accelerate advances in personalized medicine, public health and other areas of importance to Canadians and the economy

New Drug: Tecfidera for relapsing remitting multiple sclerosis

Tecfidera is indicated as monotherapy to reduce clinical exacerbations and delay time to disability due to the disease.
Primary care is best place for fibromyalgia treatment: New Canadian guidelines

‘Tender points’ no longer key to diagnosis
New MedicAlert sports band designed by teen
Prenatal valproate exposure and risk of autism spectrum disorder

Danish study looked at children exposed to valproate during pregnancy who were later diagnosed with ASD.
Calcium: is it still safe to recommend?
Should CPR guidelines be different in rural areas?
Medicine Cabinet Basics

Part one in a series designed to help pharmacists counsel patients on the self-care staples required at home
Leading edge Toronto Ottawa Heart Summit adds primary care perspective to June agenda

X

This ad will auto-close in 10 seconds